ROIV
Roivant Sciences Ltd. · Healthcare · Market cap $27.1B
Insiders sold $66.8M net in the last 90 days ·4 sellers, 0 buyers· 7 of 14 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 22, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$884.7M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Latest filing
Oct 22, 2026
Venker Eric
Roivant Sciences Ltd. (ROIV) has 94 SEC Form 4 filings (227 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Oct 22, 2026.
Inside the rolling window, 12 insiders at Roivant Sciences Ltd. reported no open-market purchases and 74 open-market sales totaling $884.7M. The most active filer is President & Immunovant CEO Venker Eric with 14 filings. Insiders have net sold $269.8M over the trailing 6 months. The most recent open-market filing is a sale of 200,000 shares by President & Immunovant CEO Venker Eric, dated Oct 20, 2026, worth $7.0M.
- Industry:Biotechnology
- CEO:Matthew Gline
- Employees:721
- HQ:London, GL, GB
- IPO:2020-12-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
| President & Immunovant CEO | Sale | 200,000 | $7.0M | Oct 22 | — | SEC ↗ | |
| Director | Sale | 17,750 | $641K | Oct 5 | +4.7% | SEC ↗ | |
| President & Immunovant CEO | Sale | 200,000 | $7.3M | Oct 2 | +4.8% | SEC ↗ | |
| Director | Sale | 4,938 | $196K | Sep 17 | -6.3% | SEC ↗ | |
| Director | Sale | 5,112 | $203K | Sep 17 | -6.3% | SEC ↗ | |
| Director | Sale | 20,000 | $798K | Sep 11 | -8.3% | SEC ↗ | |
| President & Immunovant CEO | Sale | 200,000 | $7.2M | Sep 2 | — | SEC ↗ | |
| President & CIO | Sale | 172,899 | $6.4M | Aug 22 | — | SEC ↗ | |
| President & CIO | Sale | 17,519 | $653K | Aug 22 | — | SEC ↗ | |
| President & CIO | Sale | 144,756 | $5.3M | Aug 22 | — | SEC ↗ | |
| President & CIO | Sale | 243,177 | $8.8M | Aug 19 | — | SEC ↗ | |
| President & CIO | Sale | 284,707 | $10.3M | Aug 19 | — | SEC ↗ | |
| President & CIO | Sale | 136,942 | $5.0M | Aug 19 | — | SEC ↗ | |
| President & Immunovant CEO | Sale | 200,000 | $7.0M | Jul 30 | — | SEC ↗ | |
Fitzgerald MeghanFirst in 3 months | Director | Sale | 10,000 | $349K | Jul 2 | — | SEC ↗ |
Epperly Melissa B,First in 4 months | Director | Sale | 17,750 | $610K | Jul 1 | — | SEC ↗ |
MANCHESTER KEITH SFirst in 5 months | Director | Sale | 625,783 | $21.3M | Jul 1 | — | SEC ↗ |
MANCHESTER KEITH SFirst in 5 months | Director | Sale | 800,000 | $27.6M | Jul 1 | — | SEC ↗ |
MANCHESTER KEITH SFirst in 5 months | Director | Sale | 212,380 | $7.5M | Jul 1 | — | SEC ↗ |
Gold Daniel AllenFirst in 5 months | Director | Sale | 625,783 | $21.3M | Jul 1 | — | SEC ↗ |
Gold Daniel AllenFirst in 5 months | Director | Sale | 800,000 | $27.6M | Jul 1 | — | SEC ↗ |
Gold Daniel AllenFirst in 5 months | Director | Sale | 12,380 | $437K | Jul 1 | — | SEC ↗ |
QVT Financial LPFirst in 5 months | Director by Deputization | Sale | 625,783 | $21.3M | Jun 30 | — | SEC ↗ |
QVT Financial LPFirst in 5 months | Director by Deputization | Sale | 800,000 | $27.6M | Jun 30 | — | SEC ↗ |
QVT Financial LPFirst in 5 months | Director by Deputization | Sale | 12,380 | $437K | Jun 30 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading ROIV 1 all-time
- RRep. Lisa C. McClainPurchase$1,001 - $15,0002025-06-17
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does ROIV have?
Roivant Sciences Ltd. (ROIV) has 94 SEC Form 4 filings (227 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Oct 22, 2026.
When was the most recent SEC Form 4 filing for ROIV?
The most recent Form 4 filing for ROIV on Tracefour is dated Oct 22, 2026.
Who is the most active insider at ROIV?
The most active SEC Form 4 filer at ROIV in the rolling window is President & Immunovant CEO Venker Eric, with 14 filings.
What is the net insider flow at ROIV over the last 6 months?
Over the trailing 180 days, insiders at ROIV have net sold $269.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ROIV in the current window?
Inside the rolling window, insiders at ROIV bought $0 and sold $884.7M based on SEC Form 4 filings.
Can I get alerts for ROIV insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Roivant Sciences Ltd. (ROIV). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Roivant Sciences Ltd. is in the Healthcare sector.